What Underlies the Benefit of Famotidine Formulations Used During COVID-19?
作者信息
Singh Vijay P, El-Kurdi Bara, Rood Christopher
机构信息
Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Scottsdale, Arizona.
Department of Gastroenterology, University of Texas San Antonio, San Antonio, Texas.
出版信息
Gastroenterology. 2021 Apr;160(5):1899-1900. doi: 10.1053/j.gastro.2020.07.051. Epub 2020 Aug 7.
Abstract
摘要
相似文献
1
What Underlies the Benefit of Famotidine Formulations Used During COVID-19?法莫替丁制剂在新冠疫情期间使用所带来益处的背后原因是什么？
Gastroenterology. 2021 Apr;160(5):1899-1900. doi: 10.1053/j.gastro.2020.07.051. Epub 2020 Aug 7.
2
Association Between Famotidine Use and COVID-19 Severity in Hong Kong: A Territory-wide Study.香港法莫替丁使用与新冠肺炎严重程度之间的关联：一项全港性研究。
Gastroenterology. 2021 Apr;160(5):1898-1899. doi: 10.1053/j.gastro.2020.05.098. Epub 2020 Jul 16.
3
Proton pump inhibitor or famotidine use and severe COVID-19 disease: a propensity score-matched territory-wide study.质子泵抑制剂或法莫替丁的使用与重症 COVID-19 疾病：一项倾向评分匹配的全地区研究。
Gut. 2021 Oct;70(10):2012-2013. doi: 10.1136/gutjnl-2020-323668. Epub 2020 Dec 4.
4
No Evidence Indicates Famotidine Reduces the Risk of Serious Disease in COVID-19 Patients After Propensity Score Matching: Meta-Analysis and Systematic Reviews.倾向得分匹配后，无证据表明法莫替丁可降低新冠肺炎患者患重病的风险：荟萃分析与系统评价
Dig Dis Sci. 2022 Jan;67(1):351-353. doi: 10.1007/s10620-021-07214-9. Epub 2021 Sep 1.
5
Association Between Famotidine Use and Clinical Outcomes in Patients With COVID-19: Assessment of Available Evidence.法莫替丁使用与新型冠状病毒肺炎患者临床结局之间的关联：现有证据评估
Am J Gastroenterol. 2021 Apr;116(4):848-849. doi: 10.14309/ajg.0000000000001008.
6
Famotidine and Mortality in Coronavirus Disease 2019.法莫替丁与2019冠状病毒病死亡率
Gastroenterology. 2021 Jul;161(1):361-362. doi: 10.1053/j.gastro.2020.12.045. Epub 2020 Dec 31.
7
The association between famotidine and in-hospital mortality of patients with COVID-19.法莫替丁与 COVID-19 患者住院死亡率的关联。
J Med Virol. 2022 Mar;94(3):1186-1189. doi: 10.1002/jmv.27375. Epub 2021 Oct 11.
8
Famotidine and Hospitalized COVID-19 Patients: Are the Benefits True?法莫替丁与住院的新冠病毒肺炎患者：益处是真的吗？
Am J Gastroenterol. 2021 Jul 1;116(7):1561. doi: 10.14309/ajg.0000000000001217.
9
Famotidine use and quantitative symptom tracking for COVID-19 in non-hospitalised patients: a case series.法莫替丁在非住院 COVID-19 患者中的应用及定量症状跟踪：一项病例系列研究。
Gut. 2020 Sep;69(9):1592-1597. doi: 10.1136/gutjnl-2020-321852. Epub 2020 Jun 4.
10
Use of Famotidine and Risk of Severe Course of Illness in Patients With COVID-19: A Meta-analysis.法莫替丁的使用与 COVID-19 患者重症病程风险：一项荟萃分析
Mayo Clin Proc. 2021 May;96(5):1365-1367. doi: 10.1016/j.mayocp.2021.03.001. Epub 2021 Mar 5.
引用本文的文献
1
Clinical update on COVID-19 for the emergency and critical care clinician: Medical management.COVID-19 临床更新：为急诊和危重症临床医生提供的医学管理建议
Am J Emerg Med. 2022 Jun;56:158-170. doi: 10.1016/j.ajem.2022.03.036. Epub 2022 Mar 26.
2
Experimental Search for New Means of Pathogenetic Therapy COVID-19: Inhibitor of H2-Receptors Famotidine Increases the Effect of Oseltamivir on Survival and Immune Status of Mice Infected by A/PR/8/34 (H1N1).新型冠状病毒肺炎发病机制治疗新方法的实验性探索：H2受体抑制剂法莫替丁增强奥司他韦对感染A/PR/8/34（H1N1）小鼠的生存及免疫状态的影响
J Evol Biochem Physiol. 2022;58(1):230-246. doi: 10.1134/S0022093022010203. Epub 2022 Mar 5.
3
A Birds-Eye (Re)View of Acid-Suppression Drugs, COVID-19, and the Highly Variable Literature.酸抑制药物、COVID-19及高度多样化文献的鸟瞰（再审视）
Front Pharmacol. 2021 Aug 11;12:700703. doi: 10.3389/fphar.2021.700703. eCollection 2021.
4
Does Famotidine Reduce the Risk of Progression to Severe Disease, Death, and Intubation for COVID-19 Patients? A Systemic Review and Meta-Analysis.法莫替丁能否降低新冠病毒肺炎患者进展为重症疾病、死亡及插管的风险？一项系统评价与Meta分析
Dig Dis Sci. 2021 Nov;66(11):3929-3937. doi: 10.1007/s10620-021-06872-z. Epub 2021 Feb 24.
5
Reply.回复。
Gastroenterology. 2021 Apr;160(5):1900-1901. doi: 10.1053/j.gastro.2021.01.013. Epub 2021 Jan 13.
6
Histamine receptors and COVID-19.组胺受体与 COVID-19。
Inflamm Res. 2021 Jan;70(1):67-75. doi: 10.1007/s00011-020-01422-1. Epub 2020 Nov 18.
7
COVID-19 and Gastrointestinal Disease: Implications for the Gastroenterologist.新型冠状病毒肺炎与胃肠道疾病：对胃肠病学家的启示。
Dig Dis. 2021;39(2):119-139. doi: 10.1159/000512152. Epub 2020 Oct 9.
Zotero 插件